DOCS.NYSEDoximity, INC

Form 4: Doximity Director Kira Scherer Wampler Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Kira Scherer Wampler, a director at Doximity, Inc., exercised a stock option and sold 2,500 shares of Class A Common Stock at $42 per share, according to a recent SEC Form 4 filing.

Summary

  • On November 1, 2024, Kira Scherer Wampler, a director of Doximity, Inc., executed a transaction involving the company's stock.
  • Wampler exercised a stock option to acquire 2,500 shares of Class A Common Stock.
  • Simultaneously, Wampler sold 2,500 shares of Class A Common Stock at a price of $42 per share.
  • These sales were executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted on August 24, 2023.
  • Following these transactions, Wampler directly owns 16,618 shares of Class A Common Stock.
  • Wampler also holds 489,700 shares of Class B Common Stock, each convertible into one share of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors. It is common for executives to utilize 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their insiders.
  • The use of 10b5-1 trading plans is a common strategy among corporate executives to sell shares in a compliant manner.
  • Comparable companies such as Teladoc Health (TDOC) and GoodRx Holdings (GDRX) also have similar insider transaction reporting requirements.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders, as they provide insight into insider trading activity.
  • The sale of shares could exert slight downward pressure on the stock price in the short term.

Key Dates

DateDescription
March 27, 2020Stock option vests in 36 equal monthly installments after this date.
June 10, 2020Stock option was granted.
August 24, 2023Date the Reporting Person adopted the Rule 10b5-1 trading plan.
November 01, 2024Date of the stock option exercise and stock sale.
June 09, 2030Expiration date of the stock option.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.